Probiotics: A potential immunotherapeutic approach for the treatment of schizophrenia

Related Studies

Probiotic lactobacillus plantarum 299v decreases kynurenine concentration and improves cognitive functions in patients with major depression: A double-blind, randomized, placebo controlled study

This 2019 double-blind, randomized, placebo-controlled study documented the affective and cognitive functions and biochemical parameters of 79 participants with major depressive disorder (MDD) to analyze the psychobiotic and immunomodulatory impact of the probiotic bacteria Lactobacillus Plantarum 299v (LP299v). Forty subjects were randomly selected to take a combination of SSRI antidepressant and the probiotic for 8 […]

The impact of a prebiotic-rich diet and/or probiotic supplements on human cognition: Secondary outcomes from the ‘Gut Feelings’ randomised controlled trial

Recent studies suggest that gut microbiota-targeted interventions may enhance cognitive function. This study by Freijy et al. (2024) aimed to evaluate whether a prebiotic-rich diet, a probiotic supplement, or a synbiotic combination of both could improve cognition as part of the ‘Gut Feelings’ trial. 118 persons with poor mood and the potential for dietary change […]